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Available online 23 December 2015A 33-year-old woman with no underlying systemic disease
visited our hospital with a tender, hyperpigmented skin tumor over
the right lateral chest wall for 6 months. Initially, the lesion was a
small hemorrhagic cutaneous papule. Perifocal hyperpigmentation
developed progressively and the lesion gradually enlarged to 2 cm
at its greatest diameter. On physical examination, a painful ill-
deﬁned mass-like lesion was palpated over the right lateral chest
wall. It was a 1  2 cm2 ovoid hyperpigmented skin patch with a
0.3-cm papule in the center (Fig. 1A). A simple excision was per-
formed. After the operation, the patient recovered uneventfully and
has had no local recurrence. The histological examination revealed
lobulated solid nests and strands of large epithelioid cells with
vesicular nuclei, minimal nuclear atypia, pale cytoplasm, and rare
mitoses, with inﬁltration into the dermis (Fig. 1B). Immunohis-
tochemically, the tumor cells were positive for vimentin and CD57
and negative for CD34, epithelial membrane antigen (EMA), human
melanoma black 45, estrogen receptor, S-100, and cytokeratin.
These features were consistent with a cellular variant of
neurothekeoma.
Neurothekeoma is a type of benign nerve sheath neoplasm and
presumably arises from small cutaneous nerves [1,2]. Neuro-
thekeomas have been classiﬁed as myxoid, cellular, or mixed type.
However, myxoid-type neurothekeomas have a relatively high local
recurrence rate when managed by simple local excision and appear
to be unrelated to cellular and mixed-type neurothekeomas.Conﬂicts of interest: none.
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).Nowadays, the term “neurothekeoma” should probably be reserved
for cellular or mixed-type tumors. The myxoid-type neuro-
thekeomas are considered nerve sheath myxomas [3].
Neurothekeomas encompass a spectrum of diseases with an
uncertain histogenesis. They occur in the dermis and are composed
of spindled and epithelioid cells arranged in a fascicular or
concentric whorl pattern. There is no well-deﬁned encapsulation.
Neurothekeomas histologically differ from nerve sheath myxomas
by their higher cellularity and presence of larger spindled or
epithelioid cells with vesicular nuclei. Immunohistochemically, the
tumor cells may express collagen type IV, calponin, smooth muscle
actin, Leu-7, and S-100 protein, but not nerve growth factor re-
ceptor p75, glial ﬁbrillary acidic protein, or CD34 [2].
Cellular-type neurothekeoma is a recently characterized variant
of neurothekeomas [4]. The typical histology of a cellular-type
neurothekeoma shows a lobulated dermal tumor composed of
spindled and epithelioid cells, arranged in fascicles and nests,
which are usually NK1/C3 positive, but lack immunoreactivity for S-
100 protein, indicating they are not of Schwann cell origin [1,4].
They are also negative for EMA, indicating they are not of perineural
cell origin either [2]. Histologically, most cases are poorly margin-
ated. These tumors characteristically have a lobulated or micro-
nodular architecture and are composed of nests and bundles of
epithelioid to spindled cells with pale eosinophilic cytoplasm, often
separated by dense hyaline collagen [4]. Most tumors show mild
cytologic atypia in the form of nuclear variability and small nucleoli
undergoing occasional mitoses. In the largest case series, the mean
mitotic rate was three per 10 high-power ﬁelds [4]. Other histo-
logical features might include myxoid stroma (29%), marked stro-
mal hyalinization (4%), osteoclastic giant cells (15%), notably
pleomorphic cells (25%), and active mitoses (21%, 5 per 10 high-
power ﬁelds) [4].
Cellular-type neurothekeomas tend to affect women more than
men, usually in the second and early third decades of life, with a
mean age at presentation of 15e21 years [1,2,4]. Hornick and
Fletcher [4] reported that the mean size of cellular-type neuro-
thekeomas was 1.1 cm (range: 0.3e6 cm; 90%< 2 cm) [4]. These
tumors arose most often on the upper limb (35%) and head and
neck (33%) [4]. About half of the tumors were limited to the dermis,
and half involved the superﬁcial subcutaneous tissue [4]. Completeby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Fig. 1. (A) A 1  2 cm2 ovoid hyperpigmented skin patch with a 0.3-cm papule in the center on the right lateral chest wall. (B) Histologically, there are lobulated solid nests and
strands of large epithelioid cells with vesicular nuclei, minimal nuclear atypia, pale cytoplasm, and rare mitoses, with inﬁltration into the dermis (hematoxylin and eosin 200).
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and only after incomplete excision [4].
Atypical features in cellular-type neurothekeomas have been
reported, including large size (up to 6 cm), deep penetration
(extending into skeletal muscle or subcutaneous fat, or both),
diffusely inﬁltrative borders, vascular invasion, a high mitotic rate,
and marked cytologic pleomorphism [1]. Although neuro-
thekeomas with worrisome features raise concern about the bio-
logic potential of these lesions, no recurrence has been reported
after complete resection [1,4]. Atypical histologic features seem to
have no clinical signiﬁcance [4].References
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